|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2004-1-27
|
|
pubmed:abstractText |
The characteristics of the phenotype of the malformed phenytoin-exposed infant can help to clarify the mechanism of the drug's teratogenesis. One postulated mechanism is vascular disruption.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1542-0752
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2003 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
993-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14745921-Abnormalities, Drug-Induced,
pubmed-meshheading:14745921-Abnormalities, Multiple,
pubmed-meshheading:14745921-Adult,
pubmed-meshheading:14745921-Anoxia,
pubmed-meshheading:14745921-Anticonvulsants,
pubmed-meshheading:14745921-Epilepsy,
pubmed-meshheading:14745921-Female,
pubmed-meshheading:14745921-Gestational Age,
pubmed-meshheading:14745921-Humans,
pubmed-meshheading:14745921-Infant, Newborn,
pubmed-meshheading:14745921-Ischemia,
pubmed-meshheading:14745921-Maternal Exposure,
pubmed-meshheading:14745921-Phenytoin,
pubmed-meshheading:14745921-Pregnancy,
pubmed-meshheading:14745921-Pregnancy Complications
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Multiple congenital anomalies associated with in utero exposure of phenytoin: possible hypoxic ischemic mechanism?
|
|
pubmed:affiliation |
Children's Hospital, Boston, Massachusetts, USA.
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|
